|
|
|
|
Дата |
|---|
| 15.01.2026 |
| 14.01.2026 |
| 13.01.2026 |
| 12.01.2026 |
| 09.01.2026 |
| 08.01.2026 |
| 07.01.2026 |
| 06.01.2026 |
| 05.01.2026 |
| 02.01.2026 |
Bid | Ask |
Open |
Min | Max |
Last |
Legal close |
Avg |
Оборот |
Кол-во сделок |
|---|---|---|---|---|---|---|---|
|
|
|
150.00
|
150.00
|
165.00
|
165.00
|
|
|
1 168 082 614.00
|
5 414.00
|
|
|
|
147.50
|
147.50
|
153.00
|
150.00
|
|
|
664 151 517.00
|
4 461.00
|
|
|
|
148.00
|
145.00
|
149.00
|
145.50
|
|
|
397 433 799.00
|
2 625.00
|
|
|
|
148.50
|
147.00
|
149.50
|
147.50
|
|
|
314 092 249.00
|
2 697.00
|
|
|
|
142.50
|
142.50
|
150.00
|
147.50
|
|
|
901 495 485.00
|
5 106.00
|
|
|
|
141.00
|
141.00
|
144.50
|
142.00
|
|
|
523 837 920.00
|
3 592.00
|
|
|
|
151.00
|
141.50
|
152.00
|
141.50
|
|
|
1 508 720 286.00
|
11 708.00
|
|
|
|
153.50
|
151.00
|
155.50
|
151.00
|
|
|
501 910 938.00
|
4 536.00
|
|
|
|
154.00
|
152.00
|
156.50
|
153.50
|
|
|
488 306 855.00
|
3 314.00
|
|
|
|
156.00
|
152.50
|
156.50
|
153.50
|
|
|
396 799 192.00
|
2 875.00
|
Caliway Biopharmaceuticals Co., Ltd. focuses on breakthrough medical aesthetics and inflammatory medicine discovery of small molecule therapeutics. The Company develops CBL-514 to treat subcutaneous fat. Caliway Biopharmaceuticals conducts businesses across worldwide.
